New therapeutics beyond amyloid-β and tau for the treatment of Alzheimer’s disease
Crossref DOI link: https://doi.org/10.1038/s41401-020-00565-5
Published Online: 2020-12-02
Published Print: 2021-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Zhang, Feng
Zhong, Ru-jia
Cheng, Cheng
Li, Song
Le, Wei-dong
Text and Data Mining valid from 2020-12-02
Version of Record valid from 2020-12-02
Article History
Received: 30 July 2020
Accepted: 25 October 2020
First Online: 2 December 2020
Competing interests
: The authors declare no competing interests.